Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Revel Pharmaceuticals
AddedFeb 16, 2024
UpdatedJun 18, 2026
Revel Pharmaceuticals

Revel Pharmaceuticals

Revel develops and commercializes therapeutic enzymes to treat age-related diseases and molecular damage.

HQ
San Francisco, CA, US
Founded
2019
Overview
Compare
Fundraising
Employees
Website

Revel Pharmaceuticals, founded with the mission to combat age-related diseases, focuses on developing and commercializing therapeutic enzymes. The company aims to address various conditions such as osteoarthritis, kidney disease, cardiovascular disease, skin aging, and diabetes complications by targeting and degrading age-associated molecular damage. Their innovative approach seeks to improve the quality of life for aging populations by offering cutting-edge therapeutic solutions.

Notable figures associated with Revel Pharmaceuticals include leading scientists and industry experts in biotechnology and pharmaceuticals. The company has attracted significant interest from investors focused on longevity and healthcare innovation. Key achievements include advancing their enzyme therapies through critical stages of development and securing patents for their proprietary technologies. Revel Pharmaceuticals is poised to make a substantial impact on the treatment of age-related diseases, contributing to the broader field of regenerative medicine.

Revel Pharmaceuticals - Similar Companies

Rejuveron Life Sciences logo

Rejuveron Life Sciences

rejuveron.com

Retro Biosciences logo

Retro Biosciences

retro.bio

Rejuvenate Bio logo

Rejuvenate Bio

rejuvenatebio.com

Reven Holdings logo

Reven Holdings

reven.com

Repair Biotechnologies logo

Repair Biotechnologies

Regenerative Bio logo

Regenerative Bio

regen-bio.us

Engrail Therapeutics logo

Engrail Therapeutics

engrail.com

Cambrian BioPharma logo

Cambrian BioPharma

cambrianbio.com

Rejuvitas logo

Rejuvitas

rejuvitas.com

Reiley Pharmaceuticals logo

Reiley Pharmaceuticals

Rubedo Life Sciences logo

Rubedo Life Sciences

rubedolife.com

Unity Biotechnology logo

Unity Biotechnology

Underdog Pharmaceuticals logo

Underdog Pharmaceuticals

cyclaritytx.com

Fountain Therapeutics logo

Fountain Therapeutics

fountaintx.com

Rivus Pharmaceuticals logo

Rivus Pharmaceuticals

rivuspharma.com

Revel Pharmaceuticals - Quick Facts

Who are Revel Pharmaceuticals' competitors?

Companies similar to Revel Pharmaceuticals include Rejuveron Life Sciences, Retro Biosciences, Rejuvenate Bio and Reven Holdings.

When was Revel Pharmaceuticals founded?

Revel Pharmaceuticals was founded in 2019.

Where is Revel Pharmaceuticals' headquarters located?

Revel Pharmaceuticals' headquarters is located in San Francisco, CA, US.

When was Revel Pharmaceuticals' last funding round?

Revel Pharmaceuticals' most recent funding round was for $8.4M (USD) in March 2022.

How much has Revel Pharmaceuticals raised to-date?

As of Mar 17, 2022, Revel Pharmaceuticals has raised a total of $8.4M (USD).

How many employees does Revel Pharmaceuticals have?

Revel Pharmaceuticals has 6 employees as of Feb 5, 2024.

Revel Pharmaceuticals - Classification

Ownership
  • Private
  • Venture Capital
Technology
  • Biotech
Geographic Exposure
  • Americas
Revenue
  • Licensing
  • Recurring
  • Software
Customer
  • Enterprise
Main Product
  • Enzyme Therapies
Tags
  • Biotech
  • Healthtech
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 541000Professional, Scientific, and Technical Services
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8730Research, Development, And Testing Services
  • 8731Commercial Physical and Biological Research
Show 13 more industry codes
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 620000Health Care and Social Assistance
  • 325000Chemical Manufacturing
  • 623000Nursing and Residential Care Facilities
  • 325410Pharmaceutical and Medicine Manufacturing
  • 325412Pharmaceutical Preparation Manufacturing
SIC
  • 2800Chemicals And Allied Products
  • 8000Health Services
  • 2830Drugs
  • 8040Offices And Clinics Of Other Health Practitioners
  • 2834Pharmaceutical Preparations
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified